山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2014年
10期
17-20
,共4页
杨国栋%张晓英%冯志松%任权%江毅敏
楊國棟%張曉英%馮誌鬆%任權%江毅敏
양국동%장효영%풍지송%임권%강의민
N-异喹啉-3-羧酸-L-甘氨酸苄酯%食管癌%活性氧
N-異喹啉-3-羧痠-L-甘氨痠芐酯%食管癌%活性氧
N-이규람-3-최산-L-감안산변지%식관암%활성양
N-isoquinoline-3-carbonyl-L-Glycine-benzylester%esophageal carcinoma%reactive oxygen species
目的:探讨N-异喹啉-3-羧酸-L-甘氨酸苄酯( IQ-G-OBzl)对人食管癌细胞的体内外抑制作用。`方法①体外实验:人食管癌细胞分为5-FU组、L-甘氨酸苄酯组、3-羧酸异喹啉组及IQ-G-OBzl组,分别采用相应药物干预;MTT法检测药物对细胞的IC50值;流式细胞仪检测细胞内活性氧( ROS)水平。②体内实验:制作115只小鼠食管癌移植瘤模型,分为生理盐水组、IQ-G-OBzl组、L-甘氨酸苄酯组、3-羧酸异喹组及5-FU组,分别给予相应药物干预后计算抑瘤率。结果在体外实验中IQ-G-OBzl 组的IC50高于5-FU组,但低于L-甘氨酸苄酯组、3-羧酸异喹啉组(P<0.05);IQ-G-OBzl组细胞内ROS水平明显高于L-甘氨酸苄酯组、3-羧酸异喹组及生理盐水组(P<0.05)。体内实验中IQ-G-OBzl组抑瘤率高于L-甘氨酸苄酯组及3-羧酸异喹组(P<0.05)。结论 IQ-G-OBzl体内、外均有抗食管癌作用;其作用机制可能为升高细胞内ROS水平。
目的:探討N-異喹啉-3-羧痠-L-甘氨痠芐酯( IQ-G-OBzl)對人食管癌細胞的體內外抑製作用。`方法①體外實驗:人食管癌細胞分為5-FU組、L-甘氨痠芐酯組、3-羧痠異喹啉組及IQ-G-OBzl組,分彆採用相應藥物榦預;MTT法檢測藥物對細胞的IC50值;流式細胞儀檢測細胞內活性氧( ROS)水平。②體內實驗:製作115隻小鼠食管癌移植瘤模型,分為生理鹽水組、IQ-G-OBzl組、L-甘氨痠芐酯組、3-羧痠異喹組及5-FU組,分彆給予相應藥物榦預後計算抑瘤率。結果在體外實驗中IQ-G-OBzl 組的IC50高于5-FU組,但低于L-甘氨痠芐酯組、3-羧痠異喹啉組(P<0.05);IQ-G-OBzl組細胞內ROS水平明顯高于L-甘氨痠芐酯組、3-羧痠異喹組及生理鹽水組(P<0.05)。體內實驗中IQ-G-OBzl組抑瘤率高于L-甘氨痠芐酯組及3-羧痠異喹組(P<0.05)。結論 IQ-G-OBzl體內、外均有抗食管癌作用;其作用機製可能為升高細胞內ROS水平。
목적:탐토N-이규람-3-최산-L-감안산변지( IQ-G-OBzl)대인식관암세포적체내외억제작용。`방법①체외실험:인식관암세포분위5-FU조、L-감안산변지조、3-최산이규람조급IQ-G-OBzl조,분별채용상응약물간예;MTT법검측약물대세포적IC50치;류식세포의검측세포내활성양( ROS)수평。②체내실험:제작115지소서식관암이식류모형,분위생리염수조、IQ-G-OBzl조、L-감안산변지조、3-최산이규조급5-FU조,분별급여상응약물간예후계산억류솔。결과재체외실험중IQ-G-OBzl 조적IC50고우5-FU조,단저우L-감안산변지조、3-최산이규람조(P<0.05);IQ-G-OBzl조세포내ROS수평명현고우L-감안산변지조、3-최산이규조급생리염수조(P<0.05)。체내실험중IQ-G-OBzl조억류솔고우L-감안산변지조급3-최산이규조(P<0.05)。결론 IQ-G-OBzl체내、외균유항식관암작용;기작용궤제가능위승고세포내ROS수평。
Objective To investigate antitumor ability of N-isoquinoline-3-carbonyl-L-Glycine-benzylester ( IQ-G-OB-zl)on the human esophageal carcinoma cells in vitro and in vivo .Methods ①In vitro test:there were four groups in vitro test and esophageal carcinoma cells were treated with 5-FU, (L-Gly-OBzl), IQ and IQ-G-OBzl, respectively;MTT assays were performed to assess the IC 50;Intracellular reactive oxygen species ( ROS) were detected by flow cytometry .②In vivo test:the model of esophageal carcinoma in 115 nude mice was established;there were five groups in vivo test ( NS, IQ-G-OBzl, L-G-OBzl, IQ and IQ-G-OBzl) and were treated with each compound respectively .then weight of tumor was meas-ured, the inhibition rate of tumor was calculated .Results In vitro test, the IC50 of IQ-G-OBzl group was higher than that of 5-FU group, but less than that of L-Gly-OBzl and IQ groups(P<0.05).In vivo test, the inhibition rate of IQ-G-OBzl group was higher than that of L-Gly-OBzl and IQ groups (all P<0.05);the ROS level of IQ-G-OBzl group was significant-ly higher than that of L-Gly-OBzl, IQ and NS groups(P<0.05).Conclusion IQ-G-OBzl has anti-esophageal carcinoma ability in vitro and vivo , and it has no obvious side effects , whose mechanism may be related to the increasing level of ROS.